Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126179061 | 12617906 | 1 | I | 20151211 | 20160726 | 20160803 | 20160803 | EXP | CN-ROCHE-1802904 | ROCHE | 42.00 | YR | M | Y | 63.00000 | KG | 20160803 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126179061 | 12617906 | 1 | PS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous drip | Y | BP031G1 | 63239 | 2 | G | QD | ||||||
126179061 | 12617906 | 2 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | Y | Z102A | 0 | 4 | MG | TID | ||||||
126179061 | 12617906 | 3 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | Y | Z102A | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126179061 | 12617906 | 1 | Thyroiditis subacute |
126179061 | 12617906 | 2 | Thyroiditis subacute |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126179061 | 12617906 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126179061 | 12617906 | Hepatic function abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126179061 | 12617906 | 1 | 20151206 | 20151212 | 0 | |
126179061 | 12617906 | 2 | 20151207 | 0 |